Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lower nicotine cigarettes may not lower harm.

Andrew A Strasser1, Caryn Lerman, Joseph N Cappella

  • 1Transdisciplinary Tobacco Use Center, University of Pennsylvania, USA.

LDI Issue Brief
|February 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the substitutability of fruit versus menthol and tobacco-flavored e-cigarettes on combustible cigarette cessation: Randomized clinical trial protocol.

Contemporary clinical trials communications·2026
Same author

Faster CYP2A6 increases COPD and lung cancer risk by increasing smoking quantity: a mediated mendelian randomization and observational mediation study.

Respiratory research·2026
Same author

Cigarette relighting disparities and potential implications: Survey findings from a large US probability sample.

Addictive behaviors·2026
Same author

Patterns in US Cigar Sales and Prices from 2021 to 2025: An Examination of Pack Size, Flavor, "Natural" Descriptors, and Brand.

Research square·2026
Same author

The impact of very low nicotine cigarettes on cannabis and alcohol use during a 12-week clinical trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial.

Addiction (Abingdon, England)·2026
Same journal

The Current State of Evidence on Bundled Payments.

LDI issue brief·2018
Same journal

State-Based Marketplaces Outperform Federally-Facilitated Marketplaces.

LDI issue brief·2018
Same journal

Exploring the decline of narrow networks on the 2017 ACA marketplaces.

LDI issue brief·2017
Same journal

Narrow Networks on the Individual Marketplace in 2017.

LDI issue brief·2017
Same journal

Stabilizing individual health insurance markets with subsidized reinsurance.

LDI issue brief·2017
Same journal

Issue at the Heart of Advancing the De-Adoption of Low-Value Care. Proceedings from an expert roundtable.

LDI issue brief·2017
See all related articles

New genetically modified cigarettes aim to reduce harm for smokers unable to quit. However, studies suggest these potentially reduced exposure products (PREPs) may not effectively lower smoking

Area of Science:

  • Tobacco control research
  • Public health
  • Genetically modified organisms

Background:

  • In 2005, 21% of US adults smoked, with 81% daily.
  • Smokers seeking harm reduction may consider alternatives to traditional cigarettes.
  • Potentially Reduced Exposure Products (PREPs) are designed to lower tar and/or nicotine levels.

Purpose of the Study:

  • To investigate the usage patterns of cigarettes with genetically modified tobacco designed to reduce nicotine.
  • To examine the messages smokers receive from marketing of these novel tobacco products.
  • To assess the potential of these products to mitigate smoking-related harm.

Main Methods:

  • Review of studies on the use of genetically modified tobacco cigarettes.
  • Analysis of marketing messages associated with these products.

Related Experiment Videos

  • Evaluation of user behavior and perceptions.

    • Main Results:

    • The studies indicate a cautionary signal regarding the efficacy of these products in reducing harm.
    • Understanding how these products are used is crucial for assessing their public health impact.
    • Marketing messages may influence smoker perceptions of reduced risk.

    Conclusions:

    • Genetically modified tobacco cigarettes warrant careful consideration due to uncertain harm reduction.
    • Further research is needed to validate claims of reduced health effects.
    • Regulatory oversight is essential for novel tobacco products like PREPs.